Cargando…

Preventing tissue fibrosis by local biomaterials interfacing of specific cryptic extracellular matrix information

Matrix metalloproteinases (MMPs) contribute to the breakdown of tissue structures such as the basement membrane, promoting tissue fibrosis. Here we developed an electrospun membrane biofunctionalized with a fragment of the laminin β1-chain to modulate the expression of MMP2 in this context. We demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Horejs, Christine-Maria, St-Pierre, Jean-Philippe, Ojala, Juha R. M., Steele, Joseph A. M., da Silva, Patricia Barros, Rynne-Vidal, Angela, Maynard, Stephanie A., Hansel, Catherine S., Rodríguez-Fernández, Clara, Mazo, Manuel M., You, Amanda Y. F., Wang, Alex J., von Erlach, Thomas, Tryggvason, Karl, López-Cabrera, Manuel, Stevens, Molly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472175/
https://www.ncbi.nlm.nih.gov/pubmed/28593951
http://dx.doi.org/10.1038/ncomms15509
Descripción
Sumario:Matrix metalloproteinases (MMPs) contribute to the breakdown of tissue structures such as the basement membrane, promoting tissue fibrosis. Here we developed an electrospun membrane biofunctionalized with a fragment of the laminin β1-chain to modulate the expression of MMP2 in this context. We demonstrate that interfacing of the β1-fragment with the mesothelium of the peritoneal membrane via a biomaterial abrogates the release of active MMP2 in response to transforming growth factor β1 and rescues tissue integrity ex vivo and in vivo in a mouse model of peritoneal fibrosis. Importantly, our data demonstrate that the membrane inhibits MMP2 expression. Changes in the expression of epithelial-to-mesenchymal transition (EMT)-related molecules further point towards a contribution of the modulation of EMT. Biomaterial-based presentation of regulatory basement membrane signals directly addresses limitations of current therapeutic approaches by enabling a localized and specific method to counteract MMP2 release applicable to a broad range of therapeutic targets.